These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 32642701

  • 1. Clinical utility of circulating miR-371a-3p for the management of patients with intracranial malignant germ cell tumors.
    Murray MJ, Ajithkumar T, Harris F, Williams RM, Jalloh I, Cross J, Ronghe M, Ward D, Scarpini CG, Nicholson JC, Coleman N.
    Neurooncol Adv; 2020; 2(1):vdaa048. PubMed ID: 32642701
    [Abstract] [Full Text] [Related]

  • 2. A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours.
    Murray MJ, Bell E, Raby KL, Rijlaarsdam MA, Gillis AJ, Looijenga LH, Brown H, Destenaves B, Nicholson JC, Coleman N.
    Br J Cancer; 2016 Jan 19; 114(2):151-62. PubMed ID: 26671749
    [Abstract] [Full Text] [Related]

  • 3. Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours.
    Dieckmann KP, Radtke A, Spiekermann M, Balks T, Matthies C, Becker P, Ruf C, Oing C, Oechsle K, Bokemeyer C, Hammel J, Melchior S, Wosniok W, Belge G.
    Eur Urol; 2017 Feb 19; 71(2):213-220. PubMed ID: 27495845
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA miR-371a-3p in serum of patients with germ cell tumours: evaluations for establishing a serum biomarker.
    Spiekermann M, Belge G, Winter N, Ikogho R, Balks T, Bullerdiek J, Dieckmann KP.
    Andrology; 2015 Jan 19; 3(1):78-84. PubMed ID: 25187505
    [Abstract] [Full Text] [Related]

  • 5. microRNA-371a-3p as informative biomarker for the follow-up of testicular germ cell cancer patients.
    van Agthoven T, Eijkenboom WMH, Looijenga LHJ.
    Cell Oncol (Dordr); 2017 Aug 19; 40(4):379-388. PubMed ID: 28612337
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Real-World Application of Pre-Orchiectomy miR-371a-3p Test in Testicular Germ Cell Tumor Management.
    Badia RR, Abe D, Wong D, Singla N, Savelyeva A, Chertack N, Woldu SL, Lotan Y, Mauck R, Ouyang D, Meng X, Lewis CM, Majmudar K, Jia L, Kapur P, Xu L, Frazier AL, Margulis V, Strand DW, Coleman N, Murray MJ, Amatruda JF, Lafin JT, Bagrodia A.
    J Urol; 2021 Jan 19; 205(1):137-144. PubMed ID: 32856980
    [Abstract] [Full Text] [Related]

  • 8. Micro-RNA-371a-3p in Germ Cell Testicular Tumors on Diagnosis: A Prospective Case-Control Study in Turkish Population.
    Kılınç MT, Göger YE, Özkent MS, Kılıç Ö, Okur Altındaş B, Yıldırım MS, Karalezli G.
    Urol J; 2024 Jun 09; 21(4):242-249. PubMed ID: 38629199
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Can germ cell neoplasia in situ be diagnosed by measuring serum levels of microRNA371a-3p?
    Radtke A, Cremers JF, Kliesch S, Riek S, Junker K, Mohamed SA, Anheuser P, Belge G, Dieckmann KP.
    J Cancer Res Clin Oncol; 2017 Nov 09; 143(11):2383-2392. PubMed ID: 28819887
    [Abstract] [Full Text] [Related]

  • 14. Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study.
    Dieckmann KP, Radtke A, Geczi L, Matthies C, Anheuser P, Eckardt U, Sommer J, Zengerling F, Trenti E, Pichler R, Belz H, Zastrow S, Winter A, Melchior S, Hammel J, Kranz J, Bolten M, Krege S, Haben B, Loidl W, Ruf CG, Heinzelbecker J, Heidenreich A, Cremers JF, Oing C, Hermanns T, Fankhauser CD, Gillessen S, Reichegger H, Cathomas R, Pichler M, Hentrich M, Eredics K, Lorch A, Wülfing C, Peine S, Wosniok W, Bokemeyer C, Belge G.
    J Clin Oncol; 2019 Jun 01; 37(16):1412-1423. PubMed ID: 30875280
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Combining Hypermethylated RASSF1A Detection Using ddPCR with miR-371a-3p Testing: An Improved Panel of Liquid Biopsy Biomarkers for Testicular Germ Cell Tumor Patients.
    Lobo J, van Zogchel LMJ, Nuru MG, Gillis AJM, van der Schoot CE, Tytgat GAM, Looijenga LHJ.
    Cancers (Basel); 2021 Oct 18; 13(20):. PubMed ID: 34680375
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. High Expression of microRNA-371a-3p in Cystic Fluid of Post-Chemotherapy Teratoma with Concurrent Normal Serum Levels in Patients with Non-Seminomatous Testicular Germ Cell Tumours.
    Dieckmann KP, Hennig F, Anheuser P, Gehrckens R, Viehweger F, Wülfing C, Belge G.
    Urol Int; 2021 Oct 18; 105(1-2):21-26. PubMed ID: 33049748
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA miR-371a-3p - A Novel Serum Biomarker of Testicular Germ Cell Tumors: Evidence for Specificity from Measurements in Testicular Vein Blood and in Neoplastic Hydrocele Fluid.
    Dieckmann KP, Spiekermann M, Balks T, Ikogho R, Anheuser P, Wosniok W, Loening T, Bullerdiek J, Belge G.
    Urol Int; 2016 Oct 18; 97(1):76-83. PubMed ID: 26989896
    [Abstract] [Full Text] [Related]

  • 20. CRIPTO and miR-371a-3p Are Serum Biomarkers of Testicular Germ Cell Tumors and Are Detected in Seminal Plasma from Azoospermic Males.
    Spiller CM, Lobo J, Boellaard WPA, Gillis AJM, Bowles J, Looijenga LHJ.
    Cancers (Basel); 2020 Mar 23; 12(3):. PubMed ID: 32210110
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.